Chimeric Therapeutics is trading 5.13% up at A$0.04 after the August 7, 2026 session, amid stronger biotech sentiment.
- No clear company-specific announcement, clinical update, earnings release, or broker action was identified.
- The company’s latest reported developments, including funding and strategic-review updates, predate the session.